Primarily centred from the East Coast but active on mandates throughout the country, Arnold & Porter capably combines regulatory, litigation and scientific knowledge for an impressive roster of leading pharmaceutical and medical device companies on their highest-profile product liability matters. Indeed, it is this ability to provide a full suite of services, including in relation to government investigations, that ensures that the firm is front and centre in the minds of many clients in the space when looking for a firm to take a leadership role on potentially brand-threatening aggregated proceedings. Under the guidance of New York-based Anand Agneshwar , the firm has garnered a number of notable victories for Sanofi in the sprawling MDL relating to their over-the-counter heartburn medication Zantac, including securing crucial Daubert judgments which effectively eliminated many thousands of claims. Head of the firm’s New York office, Arthur Brown  also regularly takes key leadership roles, in so doing helping to shape the strategy and work up cases ahead of trials; he continues to lead the firm’s role as national counsel to AstraZeneca in the proton pump inhibitor mass tort. Washington DC-based Paige Sharpe  is adept at defending pharmaceutical companies in both civil and governmental actions/investigations, bringing core litigation skills to bear at trial and appellate level, as well as advising on regulatory issues as well as in the context of risk management strategies. Agneshwar co-heads the overarching product liability litigation group alongside Washington DC-based Daphne O’Connor.

Informed by a deep understanding of the science and a strong strategic sensibility, Dechert LLP is a popular choice among life sciences clients as defendants in large aggregated cases alleging injury caused by pharmaceutical products as well as medical devices. Regularly taking a leadership role which draws upon highly competent lawyers spread across the East and West coasts, the team has, in recent years, secured many victories using highly persuasive dispositive motions in state and federal courts throughout the US, which have either vastly reduced the pool of plaintiffs liable for potential damages or eliminated them entirely. Based out of New York, Mark S. Cheffo  has been key to many of these successes, including for GSK in the Zantac MDL as one of the main architects of the defendants’ Daubert motion, which effectively shut the door on approximately 50,000 claims, when the judge of the MDL recently ruled that the plaintiffs had failed to show any reliable scientific evidence establishing a causal link between the heartburn drug and various cancers. New York-based Sheila L. Birnbaum  also excels at arguing Daubert motions as part of her broad expertise throughout the litigation continuum in relation to pharmaceutical MDLs.

Drawing upon lawyers with ‘first-hand medical practice experience and highly technical expertise’, DLA Piper LLP (US) combines strong procedural nous with deep subject matter knowledge, in turn being well positioned to represent life sciences clients on work throughout the litigation life cycle. As well as regularly acting as national co-ordinating counsel on large-scale domestic MDLs, the team regularly works alongside practitioners throughout its global network of offices on cross-border work, and is recognized for its ‘excellent‘ work in co-ordinating multinational law suits. In this context, ‘outstanding’ Atlanta-based Christopher Campbell continues to take the lead for Bayer on global mass tort litigation involving Essure, leveraging the knowledge and skills gleaned from the firm’s success in the initial US action to good effect on the ensuing international cases. Praised for her ‘ability to see the big picture’, as well as her ‘highly impressive knowledge of the medical facts’, Mary Gately in Washington DC has also been key to the firm’s success for Bayer. New York-based Loren Brown is well-versed in handling large-scale aggregated litigation, including his ongoing work as co-national counsel for Sanofi in the Zantac MDL; where he has gained an excellent reputation for securing the early dismissal of matters through often innovative strategies. From Boston, Matthew Holian is also very effective at representing pharmaceutical companies engaged in MDLs, being as comfortable handling discovery issues, as he is cross-examining expert witnesses in Daubert hearings and in bellwether trials. Other key individuals include Dallas-based trial lawyer Lyn Pruitt; Boston-based Katie Insogna, who excels at developing expert witnesses and on discovery matters; and New York based Lucas Przymusinski , who ‘has an incredibly scientific mind in addition to legal expertise’. 

With Midwestern roots and a national reach, dispute resolution boutique Goldman Ismail Tomaselli Brennan & Baum LLP has developed a market-leading reputation for litigating large aggregated product liability cases in state and federal courts throughout the country. Much of this work takes place in the pharmaceutical/life sciences space, where with four MD/JDs in its ranks, the firm is particularly adept at handling matters with complex and technical issues at their core. Although it does handle work throughout the litigation continuum, the team, under the leadership of  ‘incredibly smart’ Chicago-based Tarek Ismail is best-known for its trial-ready capabilities, where it excels in explaining often highly complex matters in a persuasive and simplified way to juries. A ‘top-notch strategist and excellent first-chair trial lawyer’, Shayna Cook, who is also based in Chicago, has gained a number of notable victories over the years, both in bellwether trials and in Daubert challenges, as well as other dispositive motions. Leveraging his science and medical background, Santa Monica-based Ken Baum  is also a key member of the firm’s teams in relation to large MDLs, regularly gaining early dismissals of cases through very effective depositions of key expert and treating physician witnesses. Noted for his ‘brilliant science mind’, Dallas-based Joe Tomaselli co-heads the science and experts group alongside Baum and focuses on developing and implementing winning scientific theories of the case for medical drug and device manufacturers. With ‘a poise and confidence that judges and juries both appreciate’, Chicago-based Jennifer Greenblatt is ‘laser focused on winning’, be it in a final trial or through briefing and arguing dispositive motions.

 

Combining in-depth industry expertise (including many in the team with science/medical backgrounds) with deep product liability litigation prowess in offices throughout the country, King & Spalding LLP remains a very popular choice among leading pharmaceuticals and medical device companies when faced with high-stakes litigation. Many of these matters are large-scale mass torts, where the firm regularly acts as national co-ordinating counsel, effectively mobilizing resources throughout the country, including in New York and Atlanta, to provide an all-encompassing representation throughout the litigation process. Although the firm has more than its fair share of accomplished trial lawyers within its ranks, much of the success it achieves for clients is predicated by its strong strategic sense and ability to dismiss or narrow claims at an early stage. A key part of this success is down to the firm’s ability to leverage science and medical expertise, ensuring that it is very effectively able to challenge plaintiff experts and to work with their own experts providing testimony in depositions. Andy Bayman has ‘great strategic sense’ and along with Robert Friedman  has been acting as national counsel for Boehringer Ingelheim as one of the defendants in the high-profile Zantac litigation. Notably the pair were recently part of the team that helped secure a major victory for defendants in the case with a recent very high-profile Daubert ruling which excluded all of the plaintiffs’ general causation experts and granted summary judgment for the client and co-defendants. Adam Spicer is also an integral member of the Zantac litigation team and as well as handling private litigation is also regularly involved in state Attorney General actions. Todd Davis  is a ‘very skilled trial attorney’, and has over the years been instrumental to many high-profile life sciences-related trial successes, in part due to his accomplished cross-examination skills of plaintiffs’ key causation and medical expert witnesses at trial and in deposition. In New York, both Morton Dubin and Kristen Fournier have excellent reputations at handling complex life sciences-related mass torts, with Dubin, in particular, noted for his expertise in the courtroom. Geoffrey Drake chairs the pharmaceutical/medical device litigation team and is skilled at representing clients throughout the litigation continuum, including in high-stakes trials. All named practitioners are based in Atlanta unless otherwise indicated.

 

Single office Washington  DC-based litigation powerhouse Williams & Connolly LLP has considerable experience handling complex product liability matters within the life sciences space, with well-known companies including Pfizer, GSK and AstraZeneca, regularly instructing the firm on high-profile matters relating to medicine/drugs produced by them. Many of these take the form of large MDLs involving joint defense groups, where the firm is appreciated for its strength at ‘dealing with the other counsel and acting as leaders’. With a plethora of ‘first-rate trial lawyers’ in its ranks, the firm is also noted for its courtroom capabilities, and is a regular destination practice for trials. The ‘experienced’ Joseph Petrosinelli is ‘technically terrific’, combining deep subject matter knowledge with superb advocacy skills to good effect for clients, both at a final trial, as well as at a motions stage. Although he is well-versed at handling MDLs throughout the litigation process, Paul Boehm is best-known for his trial skills. Other recommended practitioners include the ‘very talented’ Neelum Wadhwani  and Heidi Hubbard , who co-heads the team alongside Petrosinelli.

 

As one of the core industry groups within litigation boutique Bowman and Brooke LLP ‘s acclaimed product liability defense offering, pharmaceutical and medical devices work accounts for a significant volume of work for lawyers  throughout its national network of offices. The firm’s roles run the gamut from regional and local counsel, through to trial and national co-ordinating positions, with a collaborative style of working that is a great advantage on large-scale cases involving co-counsels and co-defendants. Drawing upon deep and longstanding expertise within the space, Minneapolis-based Kim Schmid has taken multiple cases to verdict in both state and federal courts, and as well as handling product liability class actions and MDLs in conventional matters – including as it relates to mesh products and breast implants – is also driving the firm’s efforts in relation to emerging litigation involving virtual clinical trials and biologics. Austin-based Randall Christian , who co-heads the team alongside Schmid, is also well-versed in trying traditional product liability cases in the space, as well as having niche expertise defending pharmaceutical companies in pricing and third-party payor litigation.

Butler Snow LLP has an ‘excellent’ record acting for pharmaceutical and medical device companies utilizing a deep bench of subject matter experts and trial lawyers. Recognized for its collaborative approach, the team works particularly well with others in a “virtual law firm” setting, with lawyers in the team who are well-versed in handling work throughout the litigation life-cycle, from discovery through to settlement negotiation. Austin-based Kim Bueno is recognized as a ‘very dynamic trial specialist’, and has scored a raft of high-profile victories in federal and state courts through the country, including a number of recent wins in pelvic mesh trials. Located in the firm’s Mississippi headquarters, Christopher Morris is excellent at managing large-scale cases, where he has developed a particularly strong reputation for realizing efficiencies, including at the discovery phase. Also based in Mississippi, Paul Rosenblatt is ‘terrific with scientific experts’, and has extensive experience preparing, defending, and cross examining case specific and general causation experts. Team head Alyson Jones is also recommended and has considerable MDL experience.

Particularly well-resourced from key offices in metropolitan centers in California, Chicago, New York and Atlanta, as well as having feet on the ground in many other regional outposts, Greenberg Traurig, LLP is well-placed to handle product liability matters for a fairly balanced array of pharmaceutical manufacturers and medical device companies, irrespective of geographical location, and is often able to handle cases without the need to instruct local counsel. The team regularly has key leadership roles on MDLs, where the offices work well together and provide expertise throughout the litigation cycle, including at a trial stage, if necessary.  Atlanta-based litigator Lori Cohen has a pre-eminent reputation for her advocacy skills, she has recently scored some excellent results for Bard as a defendant in its MDL regarding pelvic mesh.  Also based in Atlanta, Sara Thompson is an accomplished trial lawyer, as well as providing expert counselling to clients at a pre-litigation stage (on risk management strategies), and working cases up through to trial. The ‘exceptional’ New York-based Glenn Kerner regularly takes the lead on large-scale mass torts and MDLs where he is appreciated for his ability to recommend ‘strategies to resolve litigation cost effectively’. Other recommended practitioners include Gregory Ostfeld, who co-heads the team alongside Thompson from Chicago; Atlanta-based Marcella Ducca, who is particularly skilled at working up expert witnesses, including as it relates to women’s health devices and women’s health consumer products; and Sabrina Gallo in Miami, who is adept at developing case strategy, up to and including trial, for medical device companies.

Drawing upon ‘deep experience and knowledge of the law and all the technical and medical aspects required for crafting a successful defense’, Hughes Hubbard & Reed LLP‘s New York-based team has a strong reputation handling mass torts/class actions for life sciences clients, where it is appreciated for its ‘team player approach’ and ‘strategic mindset’. The team has also developed a market-leading reputation for supporting clients involved in litigation outside of the US, where they ‘work hand-in-glove with the client’s global and local legal and medical teams as well as with the respective local counsel defending the case in court’. With a ‘comprehensive approach that transcends traditional litigation’, James C. Fitzpatrick  is ‘well known for his work with scientific experts and company witnesses’, helping to effectively develop substantial domestic and international cases. The ‘detail-oriented and success driven’ Charles W. Cohen  also plays a pivotal role in navigating both class action and individual matters with global intricacies, ‘delivering a supersonic level of service that is not only efficient but also personalized’. For more conventional domestic matters, the ‘terrific’ Bill Beausoleil is ‘a subject matter expert in this area’, helping to develop and implement legal strategies that work in courtrooms across the country. Robb Patryk  co-heads the team with Fitzpatrick, and as part of his broad product liability practice regularly handles pharmaceutical-related disputes.

Combining first-chair trial skills, alongside deep subject knowledge and procedural expertise, Kirkland & Ellis LLP is a popular choice among many leading life sciences companies to defend them against high-stakes product liability disputes throughout the country. Many of these take the form of MDLs/class actions, with the firm excelling in taking on leadership roles as national co-ordinating counsel, as well as handling key hearings – where it shines at explaining complex scientific issues to juries. The firm’s longstanding relationship with Abbott Laboratories recently saw it representing the Chicago-based medical device company in an MDL stemming from allegations regarding its recalled baby formula sickened infants. The firm has also had a key role in the sprawling opiate litigation on behalf of Allergan and continues to defend it against ongoing claims by hundreds of private and public entities that opted out of the recent global settlement. Washington DC-based Mike Brock is ‘a superb trial lawyer across product lines’ and remains particularly active in the life sciences space. Brock is a key member of the team along with Washington DC-based Jennifer Levy  and Donna Welch in Chicago, with all three having a key role in the aforementioned Allergan matter.

With a reputation for driving results and strategy across multiple states and jurisdictions, Mayer Brown International LLP excels in handling high-profile product liability cases for both pharmaceutical and medical device companies. Based in New York, Henninger Bullock has forged an excellent reputation in the space and continues to represent GSK in innovator liability claims. Although he is been a bit more active of late on high-profile toxic tort matters, Chicago-based litigator Michael Olsen ‘s varied trial practice also regularly sees him handling cases in the life sciences sphere, where he is noted for his ‘clarity of thought and persuasive arguments’. Daniel Ring , who is also based in Chicago, co-heads the team alongside Bullock and Olsen, and is noted for his comprehensive coverage in the space which includes representation on complex civil class actions and state and local government investigations and litigation.

The nimble and flexible team at Morgan, Lewis & Bockius LLP excels at handling large-scale aggregated litigation, where it regularly has leadership roles on matters within the pharmaceutical and medical devices space and is able to guide clients throughout the process, from pre-litigation matters and risk management, through to the effective development of litigation strategy. In this context, the firm can provide a multi-faceted offering which leans into Food and Drug Administration (FDA) regulatory prowess as well as governmental investigations and white-collar competence, should the need arise, and is also noted for bringing in appellate lawyers at an early stage, thereby providing a strategic advantage at trial, settlement, and on appeal. The team continues to be very active in the sprawling opioid litigation, recently working with manufacturer Teva to reach a favorable settlement with all 50 US states, putting an end to a large proportion of its outstanding legal jeopardy in the area. Pittsburgh-based Wendy West Feinstein has been heavily involved handling trial work for Teva in the opioid litigation and is also lead trial and co-ordinating counsel for Philips RS in the CPAP MDL. Philadelphia-based John Lavelle also had a key role in the Philips matter, adding gravitas and expertise as a result of his many years’ experience handling trial and appellate litigation for pharmaceuticals and medical device manufacturers. Paul Zevnik and Yardena Zwang-Weissman co-head the overarching product liability and insurance recovery group from Washington DC and Los Angeles, respectively.

 

Drawing upon ‘deep products liability experience’ throughout the country, Nelson Mullins Riley & Scarborough LLP provides ‘sound counsel and advice’ to pharmaceutical manufacturers and medical device companies in disputes, irrespective of geographical location. The team also works well with others, be it in the role of national co-ordinating or regional counsel, and is appreciated for its ability to provide ‘exemplary work and strategy for clients’. Able to call upon the expertise of numerous strong trial lawyers, the team often acts as first chair in state and federal courts throughout the country, where its grasp of the underlying subject matter is greatly valued, as is its strategic sense and advocacy skills. Baltimore-based Mike Brown exemplifies these qualities, as do David Dukes  in South Carolina and Richard B. North, Jr.  in Atlanta, with all three having excellent track records, including in relation to MDL bellwether cases. Mark Jones  and Alana Bassin co-head the overarching products liability team from South Carolina and Minnesota, respectively.

Led from Houston by Brett Young and also able to draw upon resources from other key offices including Dallas and Minneapolis, Norton Rose Fulbright has significant visibility among pharmaceutical manufacturers and medical device companies, including in major class actions and MDLs. In Dallas, D’Lesli Davis , who heads up the life sciences and healthcare sub-group, has vast industry knowledge and litigation smarts with which she uses to good effect on MDLs/class actions, as well as in relation to pharmacovigilance matters. As well as regularly representing clients on personal injury matters, Davis has also gained a strong reputation advising on economic loss issues, not only on behalf of affected consumers but also third party payers. Also based in Dallas, Jonathan B. Skidmore regularly forms a pivotal part of the team’s involvement in many of the highest-profile disputes in the sector and has gained particular acclaim for his trial record. Dallas-based senior associate Ellie Norris is also recommended and has experience defending pharmaceutical manufacturers against economic loss, consumer protection, and deceptive practices claims brought by individuals, third-party payers, and state governments.

With litigation informing the majority of workflow for the firm as a whole, Shook, Hardy & Bacon LLP has deep insight into the strategic and procedural steps best suited to gaining an advantage for defendants in high-profile disputes. In the context of life sciences-related product liability, the team combines this core litigation prowess with deep subject matter prowess and substantive law knowledge to good effect, regularly working alongside the firm’s dedicated group of research analysts to provide an edge which often sees the firm prevail at an early stage in proceedings. Both based in Miami, William Geraghty  and Hildy Sastre are experienced trial lawyers, with both regularly taking the lead in high-profile bellwether cases in an a MDL setting.

With a number of ‘very talented lawyers’ spread across the firm’s national network of offices, including some well-regarded trial lawyers, Skadden, Arps, Slate, Meagher & Flom LLP regularly picks up high-profile roles for pharmaceutical/medical devices companies in consumer class action and product liability cases throughout the country. The scope of the work is broad, running the gamut from cases alleging consumer fraud and false advertising, through to mass torts alleging product defects have caused injury and/or economic loss. In these large aggregated cases the firm has gained a strong reputation taking on the role as national counsel, leading the strategy and co-ordinating with local counsel. Recognized as ‘one of the leading class action lawyers in the country’, Washington DC-based team head John Beisner leads from the front and continues to gain excellent results at trial and in the motions stage across both consumer fraud and product liability-related litigation. Other recommended practitioners include New York-based Allison Brown , who excels at explaining complex science and medical issues to juries; Jessica Davidson  in New York, who is adept at strategizing and arguing motions in life sciences-related MDLs; and Washington DC-based Nina Rose , who is particularly skilled at developing expert evidence, and challenging plaintiffs’ experts’ opinions at the Daubert stage.

Co-headed from Baltimore by Kathleen Hardway  and Jason Rose , Venable LLP‘s product liability and mass tort group has over the years developed particular expertise in the life sciences sector, marrying subject matter and regulatory prowess with a deep understanding of effective litigation tactics. Consequently, the team regularly secures leadership roles on large aggregated litigation, including acting as national counsel responsible for shaping the overarching management and strategy of MDLs. The firm’s role as co-counsel to Takeda in litigation related to its PPI medications remains a highlight of the practice, with Rose, Craig Thompson and Bruce Parker , all having pivotal roles in the matter and successfully guiding the firm to securing the dismissal of the majority of cases filed in Delaware. One of the specialized areas of practice that the firm excels in is representing vaccine manufacturers who face allegations of vaccine injury, where Dino Sangiamo is particularly skilled.

 

 

Leveraging ‘a strong overarching litigation brand’ – which includes a number of well-regarded trial lawyers based in the Midwest and on both coasts – as well as a deep knowledge of the underlying science/medicine, Winston & Strawn LLP ‘excels at handling large cases and MDLs’ involving product liability and consumer fraud allegations against pharmaceutical/medical devices companies. As well as regularly acting as lead trial counsel on high-profile matters, the team is also adept at leading the overarching litigation strategy, often acting as national counsel helping to work up the case, dealing with expert witnesses and providing expertise at a motions stage. Christopher Essig is noted for his ‘very collegiate’ approach, ensuring that he is a popular choice on large-scale MDLs often involving multiple defendants. Alongside ‘outstanding’ trial lawyer Scott Ahmad, Essig is lead national counsel for Hikma Pharmaceuticals in all of its opioid-related litigation. San Francisco-based team head Sandra Edwards  is also a very accomplished trial lawyer whose oeuvre of work has included a number of high-profile MDL successes for pharmaceutical companies over the years.

 

Leveraging significant broad-based product liability expertise, as well as overarching healthcare and life sciences sector strength that draws from a multi-disciplinary offering encompassing, inter alia, expertise in regulatory matters and government investigations, Jones Day is well-placed to quickly and effectively mobilize resources to help protect major pharmaceutical and medical device companies against challenging multi-pronged disputes. Atlanta-based Stephanie Parker  oversees the product liability practice and is one of many experienced litigators with significant trial experience with respect to matters in the life sciences space; she recently won summary judgment for a pharmaceutical company in a highly publicized case alleging death by suicide allegedly caused by a popular dermatologic drug. Chicago-based first-chair trial lawyer José Isasi is also a key member of the team, as is up-and-coming Detroit-based trial lawyer Celeste Brecht .

McGuireWoods LLP‘s broad-based product liability team has a strong pedigree representing drug and medical device manufacturers in single plaintiff and aggregated litigation, regularly securing jury trial wins, as well as acting as regional and national co-ordinating counsel on MDLs. As well as the team’s core litigation prowess, which includes the use of ADR techniques, should the need arise, the team is also noted for its deep understanding of the underlying product and the regulatory framework. Consequently, it is very effective at providing risk management strategies as well as handling product recalls. In relation to core products litigation, as well as being able to draw upon the strength of a number of highly skilled trial litigators, it also regularly achieves vital early victories at a motions stage, including as it relates to lack of jurisdiction and in Daubert challenges. Sam Tarry co-heads the overarching products liability and mass torts team alongside Justin Howard , and is noted for his aptitude at helping to develop expert witnesses as well as to explain complex scientific/medical concepts in a cogent way to juries at trial. Davis Walsh  is also a key member of the team and is particularly adept at advising on infectious disease litigation. Diane Flannery recently retired.

 

 

Instructed on a standalone basis, as well as generating some work from its well respected venture capital offering, West Coast heavyweight Morrison Foerster provides a comprehensive offering to large and emerging life sciences entities, from product development to market and beyond, in both a risk management and litigation context. On the litigation front, the team, which is led out of San Diego by Erin Bosman , ‘thinks creatively about how product liability litigation fits within the company’s larger risk management program’. Herself a former scientist, San Diego-based Julie Park is ‘attentive, responsive, efficient and results oriented’ and exemplifies the firm’s holistic approach, being adept at guiding clients throughout the product life cycle, from regulatory advice through to class action litigation.

 

Faegre Drinker Biddle & Reath is well-placed to represent medical device and pharmaceutical companies across a range of single plaintiff and mass tort actions across the US. Indianapolis-based Andrea Pierson has an excellent reputation handling medical device mass torts and continues to spearhead the firm’s ongoing work for Cook Medical on its MDL relating to its inferior vena cava filter product. In New Jersey, Susan Sharko is also very skilled at handling pharmaceutical and medical device MDL matters, where she regularly works with expert witnesses to develop the case, as well as working against opposition experts in Daubert hearings. Minneapolis-based Amy Fiterman heads up the overarching products liability and mass tort team.

Washington DC-based litigation boutique Wilkinson Stekloff is able to resource high-stakes disputes utilizing a ‘deep bench of top notch legal strategists and trial lawyers with extensive experience in products liability mass tort litigation’. The life sciences sector informs a considerable volume of these matters, with the firm lauded for its ability to simplify the narrative and explain often complicated scientific issues to juries, as well as to effectively cross-examine experts in Daubert hearings. A ‘trial lawyer with impeccable judgement’, Brian Stekloff  has an excellent pedigree in the space, both at a motions stage as well as at trial, where he has secured numerous victories in products liability bellwether trials for well-known pharmaceutical companies. As befits the reputation of ‘one of the top trial lawyers in the country’, Beth Wilkinson is able to turn her hand to a myriad disputes across subject matters, including as it relates to challenging life sciences MDLs. New York-based Keri Arnold who is gaining acclaim as being ‘the real-deal in a rising-star trial lawyers’ excels at trying cases in the life sciences space and also has extensive experience developing complex medical and scientific evidence for presentation at trial. All named practitioners are based in Washington DC, unless otherwise indicated.

Drawing upon the expertise of litigators with product liability and consumer class action experience, as well as those with overarching commercial disputes prowess, Weil, Gotshal & Manges LLP provides ‘creative and innovative’ legal strategies to pharmaceutical clients fending off potentially-brand threatening plaintiff challenges. The firm is able to advise on matters from cradle to grave, including on risk management processes, discovery and motions through to trial and appeal. New Jersey-based trial expert Diane Sullivan is one such lawyer who is in demand for her exceptional advocacy skills and ability to provide highly persuasive arguments to juries, often involving highly technical scientific information, and is regularly parachuted in on the eve of high-profile bellwether MDL trials. Recognized as an ‘excellent problem solver’, New York-based Theodore Tsekerides ‘executes and resolves’, both at a trial stage, as well as in relation to the overarching litigation strategy. On the West Coast, Silicon Valley-based David Singh co-heads the team with Sullivan and has experience of handling false advertising consumer class actions in the sector.